Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community.
These guidelines have been developed by a Working Party convened on behalf of the British Society for Antimicrobial Chemotherapy. Their aim is to provide general practitioners and other community- and hospital-based healthcare professionals with pragmatic advice about when to suspect MRSA infection in the community, when and what cultures should be performed and what should be the management options, including the need for hospitalization.
Nathwani
Dilip
D
Infection Unit, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. dilip.nathwani@nhs.net
Morgan
Marina
M
Masterton
Robert G
RG
Dryden
Matthew
M
Cookson
Barry D
BD
French
Gary
G
Lewis
Deirdre
D
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D017714:Community-Acquired Infections / Q000175:diagnosis* / Q000382:microbiology*; D006801:Humans; D016106:Methicillin Resistance; D017410:Practice Guidelines as Topic; D013203:Staphylococcal Infections / Q000175:diagnosis* / Q000188:drug therapy* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects*; D006113:United Kingdom
D000900:Anti-Bacterial Agents